EP2906298
Samtengd pýrrólóbensódíasepín - mótefni
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
11.10.2013EP published:
3.10.2018EP application number:
13785831.2
EP translation filed:
14.11.2018Grant published:
15.12.2018EPO information:
European Patent Register
Max expiry date:
10.10.2033Expiry date:
10.10.2026Next due date:
31.10.2026
Title:
PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES
Timeline
Today
11.10.2013EP application
3.10.2018EP Publication
14.11.2018Translation submitted
15.12.2018Registration published
10.10.2026Expires
Owner
Name:
ADC Therapeutics SAAddress:
Route de la Corniche 3B, 1066, Epalinges, CH
Name:
Medimmune LimitedAddress:
Milstein Building Granta Park, Cambridge, Cambridgeshire CB21 6GH, GB
Inventor
Name:
VAN BERKEL, Patricius Hendrikus CornelisAddress:
Lausanne, CH
Name:
HOWARD, Philip WilsonAddress:
LondonGreater London E1 2AX, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261712924 PDate:
12.10.2012Country:
US
Number:
201261712928 PDate:
12.10.2012Country:
US
Number:
201361784421 PDate:
14.3.2013Country:
US
Number:
201361784362 PDate:
14.3.2013Country:
US
Number:
201361784383 PDate:
14.3.2013Country:
US
Supplementary protection
SPC number:
SPC431
Classification
Categories:
A61P 39/00, A61P 35/00, A61K 47/68
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 16.11.2018
Expires: 10.10.2019
Payer: Árnason Faktor
Number: 7
Paid: 25.9.2019
Expires: 10.10.2020
Payer: Árnason Faktor
Number: 8
Paid: 25.9.2020
Expires: 10.10.2021
Payer: Árnason Faktor ehf.
Number: 9
Paid: 13.10.2021
Expires: 10.10.2022
Payer: Árnason Faktor ehf.
Number: 10
Paid: 16.9.2022
Expires: 10.10.2023
Payer: Árnason Faktor ehf.
Number: 11
Paid: 13.9.2023
Expires: 10.10.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 20.9.2024
Expires: 10.10.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 6.10.2025
Expires: 10.10.2026
Payer: Árnason Faktor ehf.